The US Food and Drug Administration (FDA) is planning to regulate the use of the cannabis compound CBD in food and supplements after weighing the evidence on the compound's safety.
The FDA will decide whether regulating legal cannabis will require new agency rules or new legislation from Congress.
Cannabis products, excluding Epidiolex, are illegal at the federal level in the US, although some states allow their use.
According to Patrick Cournoyer, who heads the FDA office developing the agency's cannabis strategy, the FDA will ascertain if CBD can be safely eaten every day for a long period or during pregnancy amid concerns about future fertility.
.


CDC Expands Ebola Screening Efforts at U.S. Entry Points Amid Congo and Uganda Outbreak
Texas Man Charged After Fatal Tesla Full Self-Driving Crash in Katy
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
Civil Rights Groups Sue Trump Administration Over Childcare Funding Freeze and Influencer's Role
Judge Approves Anthropic’s $1.5 Billion AI Copyright Settlement With Authors
Sara Duterte Impeachment Trial Opens, Putting 2028 Philippine Election in Focus
Why Maruti Suzuki Is Losing Market Share in India as SUVs and Premium Features Gain Popularity
Seven & i Eyes Żabka Stake in Major European Expansion Push
Belimo H1 Sales Surge as AI Data Center Cooling Drives More Than Half of Growth
Ryanair Warns Summer Airfares May Stay Lower as Quarterly Profit Misses Estimates
SpaceX Targets Thursday Launch for Starship's 13th Test Flight After Last-Minute Delay
DOJ Subpoenas Major Law Firms in Trump Executive Order Dispute
US Stock Futures Hold Steady as Tesla, Alphabet Earnings and Iran Conflict Dominate Market Focus
China Holds Loan Prime Rates Steady for 14th Month as Economic Recovery Remains Uneven
KKR, AEW Seek China Property Sales as Commercial Real Estate Slump Deepens
Malaysia Q2 Economy Grows 5.8%, Beating Forecasts on Strong Tech Exports and Domestic Demand
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 



